Ecteinascidin 743: A minor groove alkylator that bends DNA toward the major groove

Journal of Medicinal Chemistry

Volumn 42, Issue 14, 1999, Pages 2493-2497

  Zewail Foote, Maha ^a   Hurley, Laurence H ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRABECTEDIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; DNA STRUCTURE; DRUG DNA INTERACTION; DRUG MECHANISM;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; AUTORADIOGRAPHY; DIOXOLES; DNA; ISOQUINOLINES; NAPHTHYRIDINES; OLIGONUCLEOTIDES; TETRAHYDROISOQUINOLINES;

EID: 0033566150     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990241l     Document Type: Article

References (27)

1. Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, L. H.; Martin, D. G. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean Tunicate Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4512-4515.
2. Corey, E. J.; Gin, D. Y.; Kania, R. S. Enantioselective total synthesis of Ecteinascidin 743. J. Am. Chem. Soc. 1996, 118, 9202-9203.
3. Jimeno, J. M.; Faircloth, G.; Cameron, L.; Meely, K.; Vega, E.; Gomez, A.; Sousa-Faro, J. M. F.; Rinehart, K. Progress in the acquisition of new marine-derived anticancer compounds: development of the ecteinascidin-743 (ET 743). Drugs Future 1996, 21, 1155-1165.
4. Sakai, R.; Jares-Erijman, E. A.; Manzanares, I.; Silva Elipe, M. V.; Rinehart, K. L. Ecteinascidins: Putative biosynthetic precursors and absolute stereochemistry. J. Am. Chem. Soc. 1996, 118, 9017-9023.
5. Bowman, A.; Twelves, C.; Hoekman, K.; Simpson, A.; Smyth, J.; Vermorken, J.; Höppener, F.; Beijnen, J.; Vega, E.; Jimeno, J.; Hanauske, A.-R. Phase I clinical and pharmacokinetic (PK) study of ecteinascidin-743 (ET-743) given as a 1 h infusion every 21 days. Ann. Oncol. 1998, 9 (Suppl. 2), 119.
6. Villalona-Calero, M.; Eckhardt, S. G.; Weiss, G.; Campbell, E.; Hidalgo, M.; Kraynak, M.; Beijnen, J.; Jimeno, J.; Von Hoff, D.; Rowinsky, E. A phase I and pharmacokinetic study of ET-743, a novel DNA minor groove binder of marine origin, administered as a 1-hour infusion daily x5 days. Ann. Oncol. 1998, 9 (Suppl. 2), 119.
7. Cvitkovic, E.; Mekranter, B.; Taamma, A.; Goldwasser, F.; Beijnen, J. H.; Jimeno, J.; Riofrio, M.; Vega, E.; Misset, J. L.; Hop, P. Ecteinascidin-743 (ET-743) 24 h continuous intravenous infusion (CI) phase I study in solid tumors (ST) patients. Ann. Oncol. 1998, 9 (Suppl. 2), 119.
8. Remers, W. A. The Chemistry of Antitumor Antibiotics; John Wiley and Sons: New York, 1988; Vol. 2, pp 93-118.
9. Martinez, E. J.; Owa, T.; Schreiber, S. L.; Corey, E. J. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3496-3501.
10. Takebayashi, Y.; Pommier, Y. DNA minor groove alkylation by ecteinascidin 743 (ET743) induces sequence specific topoisomerase I-mediated DNA damage. Proc. Am. Assoc. Cancer Res. 1999, 40, 108.
11. Pommier, Y.; Kohlhagen, G.; Bailly, C.; Waring, M.; Mazumder, A.; Kohn, K. W. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry 1996, 35, 13303-13309.
12. Moore, B. M., II; Seaman, F. C.; Hurley, L. H. NMR-based model of an ecteinascidin 743-DNA adduct. J. Am. Chem. Soc. 1997, 119, 5475-5476.
13. Moore, B. M., II; Seaman, F. C.; Wheelhouse, R. T.; Hurley, L. H. Mechanism for the catalytic activation of ecteinascidin 743 and its subsequent alkylation of guanine N2. J. Am. Chem. Soc. 1998, 120, 2490-2491.
14. Seaman, F. C.; Hurley, L. H. Molecular basis for the DNA sequence selectivity of Ecteinascidin 736 and 743: Evidence for the dominant role of direct readout via hydrogen bonding. J. Am. Chem. Soc. 1998, 120, 13028-13041.
15. Rink, S. M.; Hopkins, P. B. A Mechlorethamine-induced DNA interstrand cross-link bends duplex DNA. Biochemistry 1995, 34, 1439-1445.
16. Rink, S. M.; Lipman, R.; Alley, S. C.; Hopkins, P. B.; Tomasz, M. Bending of DNA by the mitomycin C-induced, GpG intrastrand cross-link. Chem. Res. Toxicol. 1996, 9, 382-389.
17. Lee, C.-S.; Sun, D.; Kizu, R.; Hurley, L. H. Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA. Chem. Res. Toxicol. 1991, 4, 203-213.
18. Koo, H.-S.; Crothers, D. M. Calibration of DNA curvature and a unified description of sequence-directed bending. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 1763-1767.
19. Zahn, K.; Blattner, F. R. Direct evidence for DNA bending at the lambda replication origin. Science 1987, 236, 416-422.
20. Zinkel, S. S.; Crothers, D. M. DNA bend direction by phase sensitive detection. Nature 1987, 328, 178-181.
21. Koo, H.-S.; Wu, H. M.; Crothers, D. M. DNA bending at adeninethymine tract. Nature 1986, 230, 501-506.
22. Thompson, A. S.; Hurley, L. H. Solution conformation of a bizelesin A-tract duplex adduct: DNA-DNA cross-linking of an A-tract straightens out bent DNA. J. Mol. Biol. 1995, 252, 86-101.
23. Kizu, R.; Draves, P. H.; Hurley, L. H. Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA. Biochemistry 1993, 32, 8712-8722.
24. 2. J. Med. Chem. 1991, 34, 1990-1998.
25. Arora, R. K.; Cox, M. B. Molecular structure, conformation and interactions of antitumor antibiotic cyanonaphthyridinomycin, a covalent binder of DNA. J. Biomol. Struct. Dyn. 1988, 6, 489-502.
26. Cox, M. B.; Arjunan, P.; Arora, S. K. Naphthyridinomycin-DNA adducts: a molecular modeling study. J. Antibiot. 1991, 44, 885-894.
27. Borman, S. Protruding unit key to cancer drug mechanism. Chem. Eng. News 1997, 75 (June 16), 12-13.